Examples of using Sofosbuvir in English and their translations into Portuguese
{-}
-
Colloquial
-
Official
-
Medicine
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Weeks OLYSIO+ sofosbuvir.
Median sofosbuvir EC50, nM range.
Or 12 weeks SMV+ sofosbuvir.
Daklinza+ sofosbuvir for 12 weeks.
Use with ledipasvir and sofosbuvir.
People also translate
Daclatasvir+ sofosbuvir 12 weeks.
Sofosbuvir is a nucleotide prodrug.
OLYSIO in combination with sofosbuvir.
Sofosbuvir is a treatment against hepatitis C.
Daklinza in combination with sofosbuvir.
Daklinza+ sofosbuvir+ ribavirin for 12 weeks or.
Simeprevir in combination with sofosbuvir.
Daklinza+ sofosbuvir(without ribavirin) for 24 weeks.
Interaction only studied with sofosbuvir.
Or 24 weeks SMV+ sofosbuvir, with or without ribavirin4.
Daclatasvir in combination with sofosbuvir.
Sofosbuvir was administered at a dose of 400 mg once daily.
It is a combination of sofosbuvir and velpatasvir.
The active substances are ledipasvir and sofosbuvir.
The active substances are sofosbuvir and velpatasvir.
Daklinza+ sofosbuvir+ ribavirin for 12 weeks see section 5.1.
Harvoni contains the active substances ledipasvir and sofosbuvir.
Sofosbuvir is a nucleotide prodrug that is extensively metabolised.
Epclusa contains the active substances sofosbuvir and velpatasvir.
Sofosbuvir has been authorised as Sovaldi since January 2014.
In vitro potential for sofosbuvir/velpatasvir drug-drug interations.
Sofosbuvir with ribavirin and interferon appears to be around 90% effective in those with genotype 1, 4, 5, or 6 disease.
Effect on amiodarone,velpatasvir, and sofosbuvir concentrations unknown.
In clinical pharmacology studies, both sofosbuvir and GS-331007 were monitored for purposes of pharmacokinetic analyses.
Each film-coated tablet contains 400 mg sofosbuvir and 100 mg velpatasvir.